International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Changjiang Liuyu Ziyuan Yu Huanjing/Resources and Environment in the Yangtze Valley Shenyang Jianzhu Daxue Xuebao (Ziran Kexue Ban)/Journal of Shenyang Jianzhu University (Natural Science) General Medicine (ISSN:1311-1817) Chinese Journal of Evidence-Based Medicine Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation Lizi Jiaohuan Yu Xifu/Ion Exchange and Adsorption Kexue Tongbao/Chinese Science Bulletin Dalian Haishi Daxue Xuebao/Journal of Dalian Maritime University

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-03-09-2021-917
Total View : 437

Abstract :

Patients with NSCLC EGFR mutations are patients with advanced stage (stage IIIb/IV) who use targeted therapy as the main therapy such as the Tyrosine Kinase Inhibitors/TKIs (afatinib, gefitinib and erlotinib), the number of treatments received by the patient and the worsening disease prognosis can impact on the economic burden of patients and the Government. This study aims to determine the economic impact of Non-Small Cell Lung Cancer with EGFR mutations in Indonesia. This research is a retrospective observational study with a cross sectional research design that uses the perspective of health provider (health care facilities) and societal (community) conducted at Dr Sardjito Hospital Yogyakarta and Dr Kariadi Hospital Semarang, Indonesia. The results showed that the unit cost of therapy in Non-Small Cell Lung Cancer patients with EGFR mutations using afatinib therapy was Rp. 120,881,289, - and in gefitinib that is Rp. 90.750.186,-. With an average direct medical cost of Rp. 189,699, - and an indirect cost of Rp. 2.250,700.

.
Full article
International Medical Journal
Journal ID : IMJ-03-09-2021-916
Total View : 373

Abstract : Diabetes Mellitus is a chronic disease that requires a long treatment therapy so that it requires a large amount of money. This study aims to determine the use of antidiabetics and the total cost of therapy for type 2 DM patients in Riau Province, Indonesia.This type of research is observational, descriptive. To determine direct medical costs, data were taken retrospectively from the medical records of outpatient type 2 diabetes mellitus patients at Arifin Achmad Hospital between October 2016 and March 2017.Data were also taken concurrently, namely by conducting interviews to determine direct non- medical costs in patients with type 2 diabetes mellitus. The results obtained were the average total cost per month was Rp. 375,974.54. Direct medical costs include antidiabetic costs of Rp 46,430.53, complication costs of Rp 47,246.90, doctor's examination fees of Rp 25,000, laboratory examination fees of Rp 61,183.84, and diet costs of Rp 46,798.22. Direct non-medical costs include transportation costs of Rp. 24,845.36, while indirect costs are Rp. 122,954.54..
Full article
International Medical Journal
Journal ID : IMJ-02-09-2021-914
Total View : 350

Abstract : An accreditation body is a statutory organization that is usually established by an act of parliament. An accreditation body promotes development and maintenance of standard practices in patient care. Benefits of Accreditation-Patients are the biggest beneficiary among all the stakeholders, Accreditation results in high quality of care and patient safety, the patients are serviced by credentialed medical staff, Rights of patients are respected and protected. Patient’s satisfaction is regularly evaluated. Data was collected from three ICUs of the hospital. Each ICU was 10 bedded, and data was collected in three phases. In the first phase, the quality team was interviewed; in the second phase, a surprise check was done on staff of the ICU with the help of checklist, which included NABH standards; and in the third phase, the data related to quality indicators was collected for 1 year Nine indicators, applicable to the ICU were analysed 1. Needle stick injury (NSI) 2. Central line-associated blood stream infection. 3. Incidence of pressure sores. 4. Catheter-associated urinary tract infection (CAUTI) 5. Ventilator-associated pneumonia (VAP) 6. Surgical site infection (SSI) 7. Fall rate. 8. Reintubation rate within 48 hours of extubation and 9. Return to ICU within 24 hours of discharge. A functional CQI process should be focused directly on accreditation standards to result in the improvement of educational quality and outcomes, be feasible to implement, avoid duplication of effort and have both commitment and resource support from the sponsoring entity and the individual medical schools..
Full article
International Medical Journal
Journal ID : IMJ-02-09-2021-912
Total View : 384

Abstract : SARS CoV 2 infection can manifest as a mild form to life threatening pneumonia. It is also associated with wide range of secondary bacterial and fungal infections. Many cases of COVID 19 associated mucormycosis have been reported worldwide. Mucormycosis is an uncommon but a fatal angio-invasive fungal infection that usually affects patients with altered immunity. It mainly affects people who are immunocompromised, or patients already infected with other diseases. A thorough literature search was carried out across PubMed (n=35), Scopus (n=40), and Google Scholar (n=50) database using the keywords COVID 19, fungal infections, mucormycosis, diabetes mellitus, corticosteroids, ventilator, immunosuppression. The articles published till July 21, 2021, were analysed. 94% of patients with COVID-19-associated mucormycosis have a history of poorly controlled diabetes. The use of glucocorticoids for the management of COVID-19 was observed in 85% of the cases. 8% of the reported patients were suffering from haematological malignancies; 4% were on immunosuppressive therapy. Males were more affected than the females. Rhino-orbito cerebral involvement is observed in most of the cases (91%), followed by rhino-orbital involvement (14%), pulmonary (7%). The least reported are cutaneous (1%) and GIT (1%) involvement. Prevention of COVID-associated mucormycosis needs to focus on addressing the underlying risk factors: aiming for better glycemic control in those with diabetes, appropriate use of systemic corticosteroids and prevention of unnecessary use of antibiotic, antifungal and other immunomodulators..
Full article
International Medical Journal
Journal ID : IMJ-01-09-2021-911
Total View : 368

Abstract : Hypothyroidism affects cognition in a multitude of ways; however, verbal memory is a consistently affected domain. Verbal memory, which is a memory for verbally presented material, may be enhanced using semantic clustering. Imaging studies have shown that the hypothyroid brain has many functional and structural abnormalities in areas that are important for semantic clustering. The current study aimed at analyzing the semantic clustering among overt and subclinical hypothyroid subjects.46 hypothyroid subjects were contacted who were attending the outpatient ward of the Department of Endocrinology and Metabolism, Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University. 26 patients were overt hypothyroid, 20 were subclinical hypothyroid, and 20 healthy control patients were also recruited and were matched on age, education and gender. Both multivariate and univariate analyses of variance revealed a significant effect of hypothyroidism, and the hypothyroid group performed significantly inferior in comparison to the healthy controls on semantic clustering measures. It is clear from the current study's findings that hypothyroidism, whether overt or subclinical, can affect semantic clustering among young hypothyroid patients while learning new material..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//